Literature DB >> 2187882

Ultrasound screening for abdominal aortic aneurysms in patients with atherosclerotic peripheral vascular disease.

O M Shapira1, S Pasik, J P Wassermann, N Barzilai, A Mashiah.   

Abstract

The rapidly rising incidence of abdominal aortic aneurysm (AAA) and the grave prognosis in cases of rupture call for early detection and operative intervention. However, there is as yet no consensus on which groups in the population should be selected for screening. Some Authors have suggested the screening of populations at risk by virtue of their age, sex and/or the presence of arterial hypertension, and report the incidence of AAA in these populations as 5.3%, 3.4% and 0.25%, respectively. In this study we screened a group of patients with atherosclerotic peripheral vascular disease. Within this group the incidence of aneurysms was found to be 5.9%, which is at least twice the estimated incidence in the general population. Three of the six patients discovered, successfully underwent surgery. We conclude that screening of this specific population group is considerably more cost-effective than universal screening.

Entities:  

Mesh:

Year:  1990        PMID: 2187882

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  3 in total

1.  Abdominal aortic aneurysm (AAA): cost-effectiveness of screening, surveillance of intermediate-sized AAA, and management of symptomatic AAA.

Authors:  Marc D Silverstein; Stephen R Pitts; Elliot L Chaikof; David J Ballard
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-10

2.  Screening for abdominal aortic aneurysm and occlusive peripheral vascular disease in Japanese residents.

Authors:  H Takei; S Ishikawa; A Otaki; K Sakata; M Aizaki; Y Sato; M Suzuki; T Ishikita; Y Iino; T Yokoe
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

3.  Screening for abdominal aortic aneurysms in men: a Canadian perspective using Monte Carlo-based estimates.

Authors:  Bernard Montreuil; James Brophy
Journal:  Can J Surg       Date:  2008-02       Impact factor: 2.089

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.